Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 2 EP applications Daniela Deriu has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after May 26, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11746252

ANTIBODIES FOR EPIDERMAL GROWTH FACTOR RECEPTOR 3 (HER3)

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/32
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
PATENT GRANTED
EP11785007

METHODS OF TREATING FGF21-ASSOCIATED DISORDERS

IPC classification:
C07K 14/50
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS

Please Sign in to use this feature